Caregiving and Cancer Prevention: Dr. Karen Knudsen, The American Cancer Society & Jim Weiss, Real Chemistry

·37 min·2 clips

ACS is already funding and advocating for multi-cancer early detection blood tests.

1. The Real Chemistry Podcast episode with Dr. Karen Knudsen and Jim Weiss focuses on the American Cancer Society's work across research, advocacy, and patient support. 2. Dr. Karen Knudsen is CEO of the American Cancer Society and the American Cancer Society Cancer Action Network, and Jim Weiss is Real Chemistry's founder and chairman. 3. The episode asks what ACS is for now: preventing cancer, improving treatment access, and supporting patients and caregivers across the country. 4. Knudsen says ACS moved from separate regional groups to “one strong ACS against cancer” with “singularity of vision” and “singularity of mission.” 5. She says ACS aims to improve the lives of cancer patients and their families through advocacy, discovery, and patient support. 6. Her career path starts with loving science, an internship at the National Cancer Institute, and graduate work in the early 1990s when cancer genetics was emerging. 7. Knudsen describes translational science as connecting laboratory work to problems in the clinic and says that goal shaped her oncology career. 8. Her prostate cancer research focused on how testosterone drives uncontrolled cell division in the prostate and how that became a therapy target. 9. Weiss brings up Dendreon's Provenge and asks how she feels about the breakthroughs that followed her early work. 10. Knudsen says she is encouraged by new interventions such as immunotherapy and by cancer vaccines that could help prevent HPV-induced cancers. 11. She cites ACS annual data showing a 65% drop in cervical cancer incidence among women ages 20 to 24, which she links to childhood HPV vaccination. 12. She notes that ACS studies cancer incidence and mortality each year and uses those trends to decide where to invest more in research. 13. Knudsen says ACS's value proposition is the combination of research, advocacy, and patient support built on the goal of ending cancer as we know it for everyone. 14. She says ACS has more than $435 million committed in grants at any given time and remains the largest funder of cancer research outside the U.S. government. 15. She also says ACS has invested $3.3 billion in cancer research since 1991, and the country has seen a 33% overall decline in cancer mortality since that high watermark. 16. On advocacy, she points to ACS CAN and policy wins such as colonoscopy coverage after a positive home risk test, patient navigation reimbursement, and biomarker testing coverage in 14 states. 17. On patient support, she says ACS works in 5,000 communities, runs Road to Recovery rides, and operates 32 Hope Lodges that never charge patients or families. 18. Knudsen and Weiss spend a long stretch on caregivers, with ACS dedicating about $13 million in grants to caregiver support and resources like toolkits and a 24/7 call center. 19. The tone is interview-driven, practical, and policy-oriented, with a mix of personal biography, public-health statistics, and specific program details. 20. Listeners interested in oncology, prevention, screening, caregiving, and cancer policy will get the most from it, while people wanting a light, entertainment-first conversation may skip it.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Real Chemistry Podcast